| Structure | Chemical Name | CAS | MF |
|
CA-19-9, Gastric & Pancreatic Cancer, ELISA Kit
|
|
|
|
|
CA-19-9 Gastrointestinal Tumor Assoc Marker 19-9, Sialyl Lacto-N-fucopentose, Lewis A, Cl: B46,Mab anti-Hu,frozen/paraffin
|
|
|
|
|
CA242 (GASTROINTESTINAL CANCER)
|
|
|
|
|
CagA(Standard Range: 0-240 RU/ml //sensit. vs Western Blot: 93.7 %)
|
|
|
|
|
CAGCCATGGCTG, 5'-NON-PHOSPHORYLATED
|
|
|
|
|
CAGCCATGGCTG, 5'-PHOSPHORYLATED
|
|
|
|
|
CAEVM protocol
|
|
|
|
CAFLVKEVTKLIDNNKTEKEIL
|
|
C114H194N28O35S
|
|
|
C3a [Fmoc-Glu70, Ala71,72, Lys74] (70-77) [Fmoc-Glu-Ala-Ala-Leu-Lys-Leu-Ala-Arg]
|
|
|
|
|
CAf1M protein
|
141911-75-3
|
|
|
CAGED CA2+ CHANNEL ANTAGONIST
|
154026-67-2
|
C24H23ClN2O6
|
|
|
caged FEDA-ATP
|
|
|
|
|
caged sphingosine 1-phosphate
|
|
|
|
|
caged isocitrate
|
|
|
|
'CAGED GTP
|
125455-57-4
|
C18H21N6Na2O16P3
|
|
CAGED GLUTAMIC ACID
|
|
C14H15N2NaO8
|
|
CAGED GABA
|
|
C13H15N2NaO6
|
|
CAGED ASPARTIC ACID, SODIUM SALT
|
|
C13H13N2NaO8
|
|
CAGED CGMP
|
|
C18H19N6Na2O9P+2
|
|
|
Caged Glutamic Acid, Sodium Salt
|
|
|
|
|
Caged GTP, Dimethoxy-, Trisodium Salt
|
|
|
|
|
Caged GABA, Sodium Salt
|
|
|
|
|
Caged Ins(1,4,5)P3, L pack
|
|
|
|
|
Caged Ins(1,4,5)P3, S pack
|
|
|
|
|
CAGED FLUORESCEIN
|
|
|
|
|
CAGED FLUORESCEIN SULFO-OSU
|
|
|
|
CAGED INS(1,4,5)P3, TRISODIUM SALT
|
|
C14H19NNa3O17P3
|
|
CAGED ATP, DISODIUM SALT
|
171800-68-3
|
C18H24N6NaO15P3
|
|
CAGED D-ERYTHRO-SPHINGOSINE-1-PHOSPHATE
|
207516-11-8
|
C34H52N3O9P
|
|
CAGED FLUORESCEIN MALEIMIDE
|
|
C37H26N4O12
|
|
CA(FOD)2
|
36885-29-7
|
C20H20CaF14O4
|
|
CAGED FLUORESCEIN MALEIMIDE*
|
167776-24-1
|
C37H26N4O12
|
|
|
caged AIP
|
|
|
|
|
CAGEDFULLERENEDERIVATIVE
|
|
|
|
|
caged cyclic ADP-ribose
|
|
|
|
|
caged nuclear localization signal
|
|
|
|
|
CA150, exon 1 (Transcription Factor CA150, TCERG1, Transcription Elongation Regulator 1, TAF2S, TATA Box-Binding Protein-Associated Factor 2S)
|
|
|
|
|
CAGDOWN PRIMER
|
|
|
|
|
Cage for Fused Silica Column
|
|
|
|
CAGDRLTGIPSHILNSSPSD
|
|
C84H138N26O31S
|
|
|
cager-2 protein
|
|
|
|
|
CAF-PH protocol
|
|
|
|
|
cager-1 protein
|
|
|
|
|
5' CAG GAA ACA GCT ATG ACC 3'
|
|
|
|
|
CAGGCGCCTG, 5'-NON-PHOSPHORYLATED
|
|
|
|
|
CAGGCGCCTG, 5'-PHOSPHORYLATED
|
|
|
|
|
CAF-1 protein, Drosophila
|
|
|
|
|
caf1 protein, Yersinia pestis
|
|
|
|
|
CAF protocol 2
|
|
|
|
|
CAF protocol
|
|
|
|
|
CA 19-9 (GI Cancer Marker Test)
|
|
|
|
CAFRQVCHTTVPWPNASLTP
|
|
C99H150N28O27S2
|
|
CAFTARIC ACID
|
67879-58-7
|
C13H12O9
|
|
|
CAFTARIC ACID(AHP)
|
|
C13H12O9
|
|
|
Caftaric acid o-quinone
|
|
|
|
|
CAFVP protocol
|
|
|
|
|
CA549 glycoprotein
|
|
|
|
7C-aglycone
|
51732-61-7
|
C18H18O4
|
|
5C-aglycone
|
34927-45-2
|
C16H16O4
|
|
|
CA GLYCEROPHOSPHATE
|
|
|
|
|
cagocel-1
|
115774-57-7
|
|
|
|
CAG1 protein
|
147387-25-5
|
|
|
|
CAG protocol
|
|
|
|
|
CAG7 protein
|
|
|
|
|
CAG Repeat Length Mutation in Huntington's Disease
|
|
|
|
CB-52
|
869376-90-9
|
C26H43NO3
|
|
CB-86
|
1150586-64-3
|
C26H43NO3
|
|
CB 80
|
1391054-76-4
|
C6H6Cl2N2O4S2
|
|
CB 300919
|
289715-28-2
|
C32H34ClN7O2
|
|
CB 184
|
165307-47-1
|
C22H21Cl2NO2
|
|
CB 30865
|
206275-15-2
|
C26H22BrN5O2
|
|
CB 34
|
|
C21H22Cl3N3O
|
|
|
CB
|
|
|
|
10CB
|
59454-35-2
|
C23H29N
|
|
|
CB101
|
|
|
|
|
CB28
|
|
|
|
|
CB 54
|
|
|
|
CB 966
|
128312-71-0
|
C30H50O3
|
|
|
CB 182
|
|
|
|
CB 848
|
32808-58-5
|
C13H17ClO2
|
|
CB 844
|
32780-41-9
|
C13H15ClO3
|
|
|
CB105
|
|
|
|
CB 34
|
193979-75-8
|
C21H22Cl3N3O
|
|
CB-25
|
869376-63-6
|
C25H41NO3
|
|
CB 13
|
432047-72-8
|
C26H24O2
|
|
|
CAGR1 protein
|
|
|
|
|
CaiA protein
|
|
|
|
|
CAGUP PRIMER
|
|
|
|
C(14a)-Homo-27-nor-14beta-gammaceran-3alpha-ol
|
24739-08-0
|
C30H52O
|
|
|
C(14A)-HOMO-27-NORGCERA-13,15,17-TRIENE-3B,15,21A-TRIOL3,21-DIACETATE
|
|
|
|
|
C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIACETOXYPHENYL)PROPIONATE)
|
|
|
|
|
C(14A)-HOMO-27-NOR-3B,14B,21A-GCERANETRIOL3,21-DIACETATE
|
|
|
|
|
C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIMETHOXYPHENYL)PROPIONATE)
|
|
|
|
C(14a)-Homo-27-nor-5α-gammacer-13-ene
|
18070-14-9
|
C30H50
|
|
C(14a)-Homo-27-norgammacerane-3β,21α-diol
|
18188-24-4
|
C30H52O2
|
|
(14β)-C(14a)-Homo-27-norgammacerane-3,21-dione
|
25329-73-1
|
C30H48O2
|
|
C(14a)-Homo-27-norgammacerane-3β,14β,21α-triol
|
28618-19-1
|
C30H52O3
|
|
C(14a)-Homo-27-norgammacera-14-ene-3,21-dione
|
1449-07-6
|
C30H46O2
|
|
C(14a)-Homo-27-norgammacer-14-ene
|
18046-86-1
|
C30H50
|
|
C(14a)-Homo-27-norgammacer-14-ene-3β,20β,21β,24-tetrol
|
77311-65-0
|
C30H50O4
|